4//SEC Filing
Fleming Michael 4
Accession 0001127602-20-015447
CIK 0000310158other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:42 PM ET
Size
13.0 KB
Accession
0001127602-20-015447
Insider Transaction Report
Form 4
Fleming Michael
SVP Chief Ethics & Com Officer
Transactions
- Tax Payment
Common Stock
2020-05-03$77.67/sh−529$41,087→ 5,560.334 total - Award
Restricted Stock Unit
2020-05-01+2,704→ 2,704 totalFrom: 2021-05-01Exp: 2023-05-01→ Common Stock (2,704 underlying) - Exercise/Conversion
Restricted Stock Unit
2020-05-03−1,541→ 3,084 totalFrom: 2020-05-03Exp: 2022-05-03→ Common Stock (1,541 underlying) - Award
Stock Option (Right to Buy)
2020-05-01+21,144→ 21,144 totalExercise: $77.67From: 2021-05-01Exp: 2030-04-30→ Common Stock (21,144 underlying) - Exercise/Conversion
Common Stock
2020-05-03$77.67/sh+1,541$119,689→ 6,089.334 total
Footnotes (5)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
- [F5]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001772183
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:42 PM ET
- Size
- 13.0 KB